Hideyuki Hashimoto

1.1k total citations
40 papers, 902 citations indexed

About

Hideyuki Hashimoto is a scholar working on Pathology and Forensic Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hideyuki Hashimoto has authored 40 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 14 papers in Cancer Research and 12 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hideyuki Hashimoto's work include Breast Lesions and Carcinomas (16 papers), Breast Cancer Treatment Studies (10 papers) and MRI in cancer diagnosis (7 papers). Hideyuki Hashimoto is often cited by papers focused on Breast Lesions and Carcinomas (16 papers), Breast Cancer Treatment Studies (10 papers) and MRI in cancer diagnosis (7 papers). Hideyuki Hashimoto collaborates with scholars based in Japan, United States and United Kingdom. Hideyuki Hashimoto's co-authors include Takeshi Nagashima, Hiroshi Yagata, Nobuyuki Nakajima, Isamu Fukamachi, Masato Suzuki, Junji Kobayashi, Masaru Miyazaki, Kimiichi Uno, K Imazeki and Yasushi Saito and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Hideyuki Hashimoto

37 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideyuki Hashimoto Japan 15 384 247 228 207 160 40 902
Olorunsola F. Agbaje United Kingdom 15 176 0.5× 138 0.6× 123 0.5× 262 1.3× 153 1.0× 26 971
Sabine Leh Norway 23 143 0.4× 120 0.5× 64 0.3× 66 0.3× 199 1.2× 85 1.3k
Wan Wook Kim South Korea 24 198 0.5× 270 1.1× 298 1.3× 481 2.3× 668 4.2× 106 1.5k
Xiuzhong Yao China 14 231 0.6× 58 0.2× 215 0.9× 48 0.2× 113 0.7× 27 956
Baoliang Guo China 18 440 1.1× 79 0.3× 76 0.3× 457 2.2× 123 0.8× 45 1.4k
Alexi Baidoshvili Netherlands 15 346 0.9× 40 0.2× 68 0.3× 60 0.3× 128 0.8× 22 920
Isabel Amendoeira Portugal 15 224 0.6× 360 1.5× 92 0.4× 449 2.2× 191 1.2× 45 1.5k
Takumi Igura Japan 22 248 0.6× 46 0.2× 119 0.5× 123 0.6× 199 1.2× 46 1.8k
Jean‐Charles Hogue Canada 19 43 0.1× 210 0.9× 325 1.4× 331 1.6× 446 2.8× 47 986

Countries citing papers authored by Hideyuki Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Hashimoto more than expected).

Fields of papers citing papers by Hideyuki Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Hashimoto. The network helps show where Hideyuki Hashimoto may publish in the future.

Co-authorship network of co-authors of Hideyuki Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Hashimoto. A scholar is included among the top collaborators of Hideyuki Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Hashimoto. Hideyuki Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harigai, Masayoshi, et al.. (2023). A multicentre, large-scale, observational study of tocilizumab in patients with giant cell arteritis in Japan. Modern Rheumatology. 34(4). 775–783. 4 indexed citations
2.
Ito, Toshikazu, Ei Ueno, Tokiko Endo, et al.. (2023). The Japan Society of Ultrasonics in Medicine guidelines on non-mass abnormalities of the breast. Journal of Medical Ultrasonics. 50(3). 331–339. 12 indexed citations
3.
Ohe, Yuichiro, Naoya Yamazaki, Nobuyuki Yamamoto, et al.. (2022). The real-world safety of atezolizumab as second-line or later treatment in Japanese patients with non-small-cell lung cancer: a post-marketing surveillance study. Japanese Journal of Clinical Oncology. 52(6). 623–632. 7 indexed citations
4.
Takada, Mamoru, Gaku TANAKA, Hideyuki Hashimoto, et al.. (2021). Practical approach to prevent COVID-19 infection at breast cancer screening. Breast Cancer. 28(4). 969–976. 1 indexed citations
5.
Kazama, Toshiki, Yoshifumi Kuroki, Mari Kikuchi, et al.. (2012). Diffusion‐weighted MRI as an adjunct to mammography in women under 50 years of age: An initial study. Journal of Magnetic Resonance Imaging. 36(1). 139–144. 36 indexed citations
6.
Hashimoto, Hideyuki, et al.. (2008). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 17(1). 37–45. 1 indexed citations
7.
Sakakibara, Masahiro, Takeshi Nagashima, Takafumi Sangai, et al.. (2008). Breast-Conserving Surgery Using Projection and Reproduction Techniques of Surgical-Position Breast MRI in Patients with Ductal Carcinoma In Situ of the Breast. Journal of the American College of Surgeons. 207(1). 62–68. 42 indexed citations
8.
Kamiyama, Naohisa, et al.. (2008). Investigation of ultrasound image processing to improve perceptibility of microcalcifications. Journal of Medical Ultrasonics. 35(3). 97–105. 23 indexed citations
9.
Miyazaki, Osamu, Isamu Fukamachi, Atsuo Mori, et al.. (2008). Formation of preβ1-HDL during lipolysis of triglyceride-rich lipoprotein. Biochemical and Biophysical Research Communications. 379(1). 55–59. 20 indexed citations
10.
Nakamura, Rikiya, Takeshi Nagashima, Masahiro Sakakibara, et al.. (2007). Breast-conserving surgery using supine magnetic resonance imaging in breast cancer patients receiving neoadjuvant chemotherapy. The Breast. 17(3). 245–251. 20 indexed citations
11.
Nagashima, Takeshi, Takuya Ueda, Hiroshi Yagata, et al.. (2005). Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography. European Radiology. 15(7). 1353–1360. 44 indexed citations
12.
Nagashima, Takeshi, Hideyuki Hashimoto, Shigeharu Nakano, et al.. (2005). Ultrasound demonstration of mammographically detected microcalcifications in patients with ductal carcinomain situ of the breast. Breast Cancer. 12(3). 216–220. 69 indexed citations
13.
Suzuki, Masato, et al.. (2001). Quantitative morphometric analysis of fine needle aspirates of breast carcinoma. Breast Cancer. 8(2). 138–145. 6 indexed citations
14.
Hashimoto, Hideyuki, Masato Suzuki, Takeshi Nagashima, et al.. (2000). Quantitative ultrasound as a predictor of node metastases and prognosis in patients with breast cancer. Breast Cancer. 7(3). 241–246. 13 indexed citations
15.
Nagashima, Takeshi, Masato Suzuki, Hiroshi Yagata, et al.. (2000). Cytomorphometric differentiation of intraductal proliferative breast lesions. Breast Cancer. 7(1). 43–47. 15 indexed citations
16.
Nishiwaki, Masato, Toshitsugu Ishikawa, Toshimitsu Ito, et al.. (1994). Effects of alcohol on lipoprotein lipase, hepatic lipase, cholesteryl ester transfer protein, and lecithin:cholesterol acyltransferase in high-density lipoprotein cholesterol elevation. Atherosclerosis. 111(1). 99–109. 87 indexed citations
17.
Kobayashi, Junji, et al.. (1993). Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clinica Chimica Acta. 216(1-2). 113–123. 115 indexed citations
18.
Itoh, Yoshihisa, et al.. (1992). Enzyme-linked immunosorbent assay for serum pseudocholinesterase. Clinica Chimica Acta. 207(1-2). 11–18. 5 indexed citations
19.
Tashiro, Jun, Kohji Shirai, Yasushi Saito, et al.. (1992). Effects of substitutions of glycine and asparagine for serine132 on activity and binding of human lipoprotein lipase to very low density lipoproteins. FEBS Letters. 298(1). 36–38. 4 indexed citations
20.
Inadera, Hidekuni, Kohji Shirai, Hideyuki Hashimoto, et al.. (1992). Moderate oxidation of hypertriglyceridemic low-density lipoprotein causes apolipoprotein B epitope change and enhances its uptake by macrophages. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1126(1). 60–64. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026